Importantly, circulating GFP+ tumor cells had significantly enhanced expression of Nanog, Sox2, and Oct4 (Oct4B and Oct4B1) compared with those directly injected into the mammary fat pads (Fig. 1b). This evidence concerns the gene POU5F1 and neoplasm.